English

IDEX Biometrics ASA

ESEF

Report (type unavailable) · filed 2025-05-08

Annual consolidated revenue for 2024: about USD 841K, using the latest reported figures. The previous period, 2023, was about USD 4.138M.

Inspect reported changes Compare with another company Historical disclosures Segments

Watchlist

Latest fiscal year

Revenue

841 thousand USD

2024 · USD

Exact inputs and evidence

Revenue: 841000 USD Source

Operating margin

-2,604.4%

2024 · %

Exact inputs and evidence

Operating Income: -21903000 USD Source
Revenue: 841000 USD Source

Operating cash flow

-17.5 million USD

2024 · USD

Exact inputs and evidence

Operating Cash Flow: -17534000 USD Source

Free cash flow

-27.2 million USD

2023 · USD

Exact inputs and evidence

Operating Cash Flow: -27005000 USD Source
Capital Expenditure: 243000 USD Source

Cash and cash equivalents: 2.01 million USD 2024-12-31 Source
Exact value

2011000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-05-08.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2024-12-31
Operating income: 6 of 11 periods available· newest 2024-12-31
net income: No compatible figures in this window
Operating cash flow: 6 of 11 periods available· newest 2024-12-31
Capital expenditure: 5 of 11 periods available· newest 2023-12-31
Total assets: 5 of 11 periods available· newest 2024-12-31
Total liabilities: 5 of 11 periods available· newest 2024-12-31
Current assets: 5 of 11 periods available· newest 2024-12-31
Current liabilities: 5 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2024-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-79.7%

Prior period

USD 4.14 million

2023-01-01 – 2023-12-31
Current period

USD 841,000

2024-01-01 – 2024-12-31

Exact inputs and evidence

841000 − 4138000 = -3297000 USD

4138000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
841000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · IDEX Biometrics ASA · 2024-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Year-over-year change in Revenue: -3297000 USD Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 841000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2024-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2024-12-31.zip#511429 Filing: 5967007LIEEXZXHECW11-2024-12-31-ESEF-NO-0 Input fundies:Revenue: 4138000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2024-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2024-12-31.zip#511768 Filing: 5967007LIEEXZXHECW11-2024-12-31-ESEF-NO-0
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 9.47 million

Prior period

−USD 27.01 million

2023-01-01 – 2023-12-31
Current period

−USD 17.53 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-17534000 − -27005000 = 9471000 USD

-27005000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-17534000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IDEX Biometrics ASA · 2024-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Year-over-year change in Operating cash flow: 9471000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -17534000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2024-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2024-12-31.zip#646224 Filing: 5967007LIEEXZXHECW11-2024-12-31-ESEF-NO-0 Input fundies:OperatingCashFlow: -27005000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2024-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2024-12-31.zip#646605 Filing: 5967007LIEEXZXHECW11-2024-12-31-ESEF-NO-0
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue USD 841,000 100% of revenue
Operating costs Derived USD 22.74 million 2,704% of revenue
Operating income −USD 21.9 million −2,604% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow −USD 17.53 million −2,085% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.
2021 Not shown: operating income or net income is not reported.
2022 Not shown: operating income or net income is not reported.
2023 Not shown: operating income or net income is not reported.
2024 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	424000	32471000 Derived	-32047000	Unavailable	Unavailable	-28018000 Derived	Source 2019-01-01 – 2019-12-31: 424000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -32047000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -27168000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 850000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	1095000	27497000 Derived	-26402000	Unavailable	Unavailable	-23446000 Derived	Source 2020-01-01 – 2020-12-31: 1095000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -26402000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -23294000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 152000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	2840000	34190000 Derived	-31350000	Unavailable	Unavailable	-27674000 Derived	Source 2021-01-01 – 2021-12-31: 2840000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -31350000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -27533000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 141000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	4091000	35460000 Derived	-31369000	Unavailable	Unavailable	-31637000 Derived	Source 2022-01-01 – 2022-12-31: 4091000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -31369000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -31370000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 267000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	4138000	30985000 Derived	-26847000	Unavailable	Unavailable	-27248000 Derived	Source 2023-01-01 – 2023-12-31: 4138000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -26847000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -27005000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 243000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	841000	22744000 Derived	-21903000	Unavailable	Unavailable	Unavailable	Source 2024-01-01 – 2024-12-31: 841000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -21903000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -17534000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 841K 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	424000	Revenue: 424000 Open source
20202020-12-31	Revenue	1095000	Revenue: 1095000 Open source
20212021-12-31	Revenue	2840000	Revenue: 2840000 Open source
20222022-12-31	Revenue	4091000	Revenue: 4091000 Open source
20232023-12-31	Revenue	4138000	Revenue: 4138000 Open source
20242024-12-31	Revenue	841000	Revenue: 841000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-79.7% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 424000 Open source
20202020-12-31	Year over year	158.3%	Revenue: 1095000 Open source Revenue: 424000 Open source
20212021-12-31	Year over year	159.4%	Revenue: 2840000 Open source Revenue: 1095000 Open source
20222022-12-31	Year over year	44%	Revenue: 4091000 Open source Revenue: 2840000 Open source
20232023-12-31	Year over year	1.1%	Revenue: 4138000 Open source Revenue: 4091000 Open source
20242024-12-31	Year over year	-79.7%	Revenue: 841000 Open source Revenue: 4138000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2,604.4% 2024

Free cash flow margin -658.5% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	-7,558.3%	Operating Income: -32047000 Open source Revenue: 424000 Open source
20202020-12-31	Operating margin	-2,411.1%	Operating Income: -26402000 Open source Revenue: 1095000 Open source
20212021-12-31	Operating margin	-1,103.9%	Operating Income: -31350000 Open source Revenue: 2840000 Open source
20222022-12-31	Operating margin	-766.8%	Operating Income: -31369000 Open source Revenue: 4091000 Open source
20232023-12-31	Operating margin	-648.8%	Operating Income: -26847000 Open source Revenue: 4138000 Open source
20242024-12-31	Operating margin	-2,604.4%	Operating Income: -21903000 Open source Revenue: 841000 Open source
2019-12-31	Net margin	Not reported	Revenue: 424000 Open source
2020-12-31	Net margin	Not reported	Revenue: 1095000 Open source
2021-12-31	Net margin	Not reported	Revenue: 2840000 Open source
2022-12-31	Net margin	Not reported	Revenue: 4091000 Open source
2023-12-31	Net margin	Not reported	Revenue: 4138000 Open source
2024-12-31	Net margin	Not reported	Revenue: 841000 Open source
20192019-12-31	Free cash flow margin	-6,608%	Revenue: 424000 Open source Operating Cash Flow: -27168000 Open source Capital Expenditure: 850000 Open source
20202020-12-31	Free cash flow margin	-2,141.2%	Revenue: 1095000 Open source Operating Cash Flow: -23294000 Open source Capital Expenditure: 152000 Open source
20212021-12-31	Free cash flow margin	-974.4%	Revenue: 2840000 Open source Operating Cash Flow: -27533000 Open source Capital Expenditure: 141000 Open source
20222022-12-31	Free cash flow margin	-773.3%	Revenue: 4091000 Open source Operating Cash Flow: -31370000 Open source Capital Expenditure: 267000 Open source
20232023-12-31	Free cash flow margin	-658.5%	Revenue: 4138000 Open source Operating Cash Flow: -27005000 Open source Capital Expenditure: 243000 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 841000 Open source Operating Cash Flow: -17534000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -17.5M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	-27168000	Operating Cash Flow: -27168000 Open source
20202020-12-31	Operating cash flow	-23294000	Operating Cash Flow: -23294000 Open source
20212021-12-31	Operating cash flow	-27533000	Operating Cash Flow: -27533000 Open source
20222022-12-31	Operating cash flow	-31370000	Operating Cash Flow: -31370000 Open source
20232023-12-31	Operating cash flow	-27005000	Operating Cash Flow: -27005000 Open source
20242024-12-31	Operating cash flow	-17534000	Operating Cash Flow: -17534000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -27.2M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	-28018000	Operating Cash Flow: -27168000 Open source Capital Expenditure: 850000 Open source
20202020-12-31	Free cash flow	-23446000	Operating Cash Flow: -23294000 Open source Capital Expenditure: 152000 Open source
20212021-12-31	Free cash flow	-27674000	Operating Cash Flow: -27533000 Open source Capital Expenditure: 141000 Open source
20222022-12-31	Free cash flow	-31637000	Operating Cash Flow: -31370000 Open source Capital Expenditure: 267000 Open source
20232023-12-31	Free cash flow	-27248000	Operating Cash Flow: -27005000 Open source Capital Expenditure: 243000 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: -17534000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

54.2% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Liabilities / assets	Not reported	No source recorded
20202020-12-31	Liabilities / assets	26.4%	Total Liabilities: 4492000 Open source Total Assets: 17006000 Open source
20212021-12-31	Liabilities / assets	10.2%	Total Liabilities: 4301000 Open source Total Assets: 42026000 Open source
20222022-12-31	Liabilities / assets	21.3%	Total Liabilities: 6175000 Open source Total Assets: 29016000 Open source
20232023-12-31	Liabilities / assets	54.6%	Total Liabilities: 13628000 Open source Total Assets: 24962000 Open source
20242024-12-31	Liabilities / assets	54.2%	Total Liabilities: 5584000 Open source Total Assets: 10297000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.67× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Current assets / current liabilities	Not reported	No source recorded
20202020-12-31	Current assets / current liabilities	2.6×	Current Assets: 10838000 Open source Current Liabilities: 4165000 Open source
20212021-12-31	Current assets / current liabilities	8.71×	Current Assets: 37348000 Open source Current Liabilities: 4290000 Open source
20222022-12-31	Current assets / current liabilities	4.74×	Current Assets: 23835000 Open source Current Liabilities: 5033000 Open source
20232023-12-31	Current assets / current liabilities	1.64×	Current Assets: 20312000 Open source Current Liabilities: 12390000 Open source
20242024-12-31	Current assets / current liabilities	2.67×	Current Assets: 9255000 Open source Current Liabilities: 3461000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	Unavailable Not reported for this period.	−USD 27.17 million Exact value Exact value: -27168000 USD 2019-01-01 – 2019-12-31: -27168000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEX Biometrics ASA · 2019-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Operating Cash Flow: -27168000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27168000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2021-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2021-12-31-en.zip#7990354 Filing: 5967007LIEEXZXHECW11-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	USD 850,000 Exact value Exact value: 850000 USD 2019-01-01 – 2019-12-31: 850000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEX Biometrics ASA · 2019-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Capital Expenditure: 850000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 850000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2021-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2021-12-31-en.zip#7992039 Filing: 5967007LIEEXZXHECW11-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−USD 28.02 million Calculation and evidence -27168000 − 850000 USD Exact free cash flow: -28018000 USD 2019-01-01 – 2019-12-31: -27168000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 850000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEX Biometrics ASA · 2019-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Free cash flow: -28018000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27168000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2021-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2021-12-31-en.zip#7990354 Filing: 5967007LIEEXZXHECW11-2021-12-31-ESEF-NO-0 Input fundies:CapitalExpenditure: 850000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2021-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2021-12-31-en.zip#7992039 Filing: 5967007LIEEXZXHECW11-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	Unavailable Not reported for this period.	−USD 23.29 million Exact value Exact value: -23294000 USD 2020-01-01 – 2020-12-31: -23294000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEX Biometrics ASA · 2020-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Operating Cash Flow: -23294000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23294000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2021-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2021-12-31-en.zip#7989906 Filing: 5967007LIEEXZXHECW11-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	USD 152,000 Exact value Exact value: 152000 USD 2020-01-01 – 2020-12-31: 152000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEX Biometrics ASA · 2020-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Capital Expenditure: 152000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 152000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2021-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2021-12-31-en.zip#7995760 Filing: 5967007LIEEXZXHECW11-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−USD 23.45 million Calculation and evidence -23294000 − 152000 USD Exact free cash flow: -23446000 USD 2020-01-01 – 2020-12-31: -23294000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 152000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEX Biometrics ASA · 2020-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Free cash flow: -23446000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23294000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2021-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2021-12-31-en.zip#7989906 Filing: 5967007LIEEXZXHECW11-2021-12-31-ESEF-NO-0 Input fundies:CapitalExpenditure: 152000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2021-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2021-12-31-en.zip#7995760 Filing: 5967007LIEEXZXHECW11-2021-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	Unavailable Not reported for this period.	−USD 27.53 million Exact value Exact value: -27533000 USD 2021-01-01 – 2021-12-31: -27533000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEX Biometrics ASA · 2021-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Operating Cash Flow: -27533000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27533000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7704918 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	USD 141,000 Exact value Exact value: 141000 USD 2021-01-01 – 2021-12-31: 141000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEX Biometrics ASA · 2021-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Capital Expenditure: 141000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 141000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7706586 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−USD 27.67 million Calculation and evidence -27533000 − 141000 USD Exact free cash flow: -27674000 USD 2021-01-01 – 2021-12-31: -27533000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 141000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEX Biometrics ASA · 2021-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Free cash flow: -27674000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27533000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7704918 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 Input fundies:CapitalExpenditure: 141000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7706586 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	Unavailable Not reported for this period.	−USD 31.37 million Exact value Exact value: -31370000 USD 2022-01-01 – 2022-12-31: -31370000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEX Biometrics ASA · 2022-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Operating Cash Flow: -31370000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31370000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7704505 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	USD 267,000 Exact value Exact value: 267000 USD 2022-01-01 – 2022-12-31: 267000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEX Biometrics ASA · 2022-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Capital Expenditure: 267000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 267000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7706157 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−USD 31.64 million Calculation and evidence -31370000 − 267000 USD Exact free cash flow: -31637000 USD 2022-01-01 – 2022-12-31: -31370000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 267000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEX Biometrics ASA · 2022-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Free cash flow: -31637000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31370000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7704505 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 Input fundies:CapitalExpenditure: 267000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7706157 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	Unavailable Not reported for this period.	−USD 27.01 million Exact value Exact value: -27005000 USD 2023-01-01 – 2023-12-31: -27005000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEX Biometrics ASA · 2023-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Operating Cash Flow: -27005000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27005000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2024-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2024-12-31.zip#646605 Filing: 5967007LIEEXZXHECW11-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	USD 243,000 Exact value Exact value: 243000 USD 2023-01-01 – 2023-12-31: 243000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDEX Biometrics ASA · 2023-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Capital Expenditure: 243000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 243000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7705728 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	−USD 27.25 million Calculation and evidence -27005000 − 243000 USD Exact free cash flow: -27248000 USD 2023-01-01 – 2023-12-31: -27005000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 243000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDEX Biometrics ASA · 2023-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Free cash flow: -27248000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27005000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2024-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2024-12-31.zip#646605 Filing: 5967007LIEEXZXHECW11-2024-12-31-ESEF-NO-0 Input fundies:CapitalExpenditure: 243000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2023-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2023-12-31.zip#7705728 Filing: 5967007LIEEXZXHECW11-2023-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	Unavailable Not reported for this period.	−USD 17.53 million Exact value Exact value: -17534000 USD 2024-01-01 – 2024-12-31: -17534000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDEX Biometrics ASA · 2024-12-31 IDEX Biometrics ASA (esef:5967007LIEEXZXHECW11) Operating Cash Flow: -17534000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T05:04:05Z Snapshot: d3970aecb6b3ceeab2d0473a3a902deac269f1eab4284fde6395ad9192008c8f Dimensions: Consolidated View: https://fundies.io/companies/esef/5967007LIEEXZXHECW11/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17534000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://filings.xbrl.org/5967007LIEEXZXHECW11/2024-12-31/ESEF/NO/0/5967007LIEEXZXHECW11-2024-12-31.zip#646224 Filing: 5967007LIEEXZXHECW11-2024-12-31-ESEF-NO-0 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

3 filings · 331 latest values · 331 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 5967007LIEEXZXHECW11, esef:5967007LIEEXZXHECW11

IDEX Biometrics ASA

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Operating cash flow

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation